BioCentury | Sep 15, 2003
Company News

nanotype, J&J other research news

...as well as to detect and quantify the amount of a given antigen in solution. nanotype GmbH...
BioCentury | Jul 21, 2003
Company News

nanotype other research news

...resolve single-base pair mismatches and to overcome cross-reactions of antibodies in a protein biochip application. nanotype GmbH...
BioCentury | Feb 11, 2002
Politics, Policy & Law

German proteome consortium

...GmbH (Greifswald); Definiens AG (Munich); Lion bioscience AG (NMarkt:LIO; LEON, Heidelberg); MTM Laboratories AG (Heidelberg); Nanotype GmbH...
BioCentury | Dec 17, 2001
Company News

nanotype, Xerion Pharmaceuticals GmbH deal

...targets using its Xcelerate technology, then validate the targets using its XCALIbur protein inactivation technology. nanotype...
...the deal is partially funded by a grant from the German Ministry of Research (BMBF). nanotype GmbH...
BioCentury | Dec 13, 2001
Company News

nanotype, Xerion biochip deal

...a biochip to analyze neural stem cell behavior and differentiation. In the 12-month feasibility study, nanotype...
BioCentury | Dec 10, 2001
Company News

nanotype board of directors update

nanotype GmbH, Munich, Germany Business: Proteomics Appointed: Dietrich Haarer, former head of physics research at Bayer AG ; and Carsten Stoldt, CEO of Capital Stage Consult Resigned: Filipp Oesterhelt; and Boris Steipe WIR Staff...
Items per page:
1 - 6 of 6
BioCentury | Sep 15, 2003
Company News

nanotype, J&J other research news

...as well as to detect and quantify the amount of a given antigen in solution. nanotype GmbH...
BioCentury | Jul 21, 2003
Company News

nanotype other research news

...resolve single-base pair mismatches and to overcome cross-reactions of antibodies in a protein biochip application. nanotype GmbH...
BioCentury | Feb 11, 2002
Politics, Policy & Law

German proteome consortium

...GmbH (Greifswald); Definiens AG (Munich); Lion bioscience AG (NMarkt:LIO; LEON, Heidelberg); MTM Laboratories AG (Heidelberg); Nanotype GmbH...
BioCentury | Dec 17, 2001
Company News

nanotype, Xerion Pharmaceuticals GmbH deal

...targets using its Xcelerate technology, then validate the targets using its XCALIbur protein inactivation technology. nanotype...
...the deal is partially funded by a grant from the German Ministry of Research (BMBF). nanotype GmbH...
BioCentury | Dec 13, 2001
Company News

nanotype, Xerion biochip deal

...a biochip to analyze neural stem cell behavior and differentiation. In the 12-month feasibility study, nanotype...
BioCentury | Dec 10, 2001
Company News

nanotype board of directors update

nanotype GmbH, Munich, Germany Business: Proteomics Appointed: Dietrich Haarer, former head of physics research at Bayer AG ; and Carsten Stoldt, CEO of Capital Stage Consult Resigned: Filipp Oesterhelt; and Boris Steipe WIR Staff...
Items per page:
1 - 6 of 6